Control of estrone sulfatase activity in human breast cancer cells: Effect of tibolone and its metabolites

References

• Segaloff A. Hormones and mammary carcinogenesis. Breast Cancer 2: Advances in Research and Treatment , W. L. McGuire. Plenum, New York 1978; 1–22
   Google Scholar
• Kirschner M. A. The role of hormones in the development of human breast cancer. Breast Cancer 3: Advances in Research and Treatment, Current Topics , W. L. McGuire. Plenum, New York 1979; 199–226
   Google Scholar
• Osborne C. K., Hobbs K., Clark G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 1985; 45: 584–90
   PubMed Web of Science ®Google Scholar
• Lippman M. E., Dickson R. B., Bates S., Knabbe C., Huff K., Swain S., McManaway M., Bronzert D., Kasid A., Gelmann E. P. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat. 1986; 7: 59–70
   PubMed Web of Science ®Google Scholar
• Henderson B. E., Ross R., Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res. 1988; 48: 246–53
   PubMed Web of Science ®Google Scholar
• Hall J. M., Lee M. K., Newman B., Horrow J. E., Anderson L. A., Huey B., King M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9
   PubMed Web of Science ®Google Scholar
• Cropp C. S., Nevanlinna H. A., PyrhQnen S., Stenman U. H., Salmikangas P., Albertsen H., White R., Callahan R. Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res. 1994; 54: 2548–51
   Google Scholar
• Wooster R., Neuhausen S. L., Mangion J., et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088–90
   PubMed Web of Science ®Google Scholar
• Wooster R., Bignell G., Lancaster J., et al. Identification of the breast cancer susceptibility gene. BRCA2. Nature (London) 1995; 378: 789–92
   PubMed Web of Science ®Google Scholar
• Dao T. L., Hayes C., Libby P. R. Steroid sulfatase activities in human breast tumors. Proc. Soc. Expl. Biol. Med. 1974; 146: 381–4
   PubMed Web of Science ®Google Scholar
• Vignon F., Terqui M., Wesdey B., Derocq D., Rochefort H. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology 1980; 106: 1079–86
   PubMed Web of Science ®Google Scholar
• Tseng L., Mazella J., Lee L. Y., Stone M. L. Estrogen sulfatase and estrogen sulfo-transferase in human primary mammary carcinoma. J. Steroid Biochem. 1983; 19: 1413–17
   PubMedGoogle Scholar
• Pasqualini J. R., Gelly C., Lecerf F. Biological effects and morphological responses to estriol, estriol-3-sulfate, estriol-17-sulfate and tamoxifen in a tamoxifen-resistant cell line (R-27) derived from MCF-7 human breast cancer cells. Eur. J. Cancer Clin. Oncol. 1986; 22: 1495–501
   PubMed Web of Science ®Google Scholar
• Pasqualini J. R., Gelly C., Nguyen B. L., Vella C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 1989; 34: 155–63
   PubMedGoogle Scholar
• Pasqualini J. R., Schatz B., Varin C., Nguyen B. L. Recent data on estrogen sulfatase and sulfotransferase activities in human breast cancer. J. Steroid Biochem. Molec. Biol. 1992; 41: 323–9
   PubMed Web of Science ®Google Scholar
• Perel E., Wilkins D., Killinger D. W. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. J. Steroid Biochem. 1980; 13: 89–94
   PubMedGoogle Scholar
• Silva M. C., Rowlands M. G., Dowsett M., Gusterson B., McKinna J. A., Fryatt I., Coombes R. C. Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res. 1989; 49: 2588–91
   Google Scholar
• Pollow K., Boquoi E., Baumann J., Schmidt-Gollwitzer M., Pollow B. Comparison of thein vitro conversion of estradiol-17b˜ to estrone of normal and neoplastic human breast tissue. Molec. Cell. Endocr. 1977; 6: 333–48
   PubMed Web of Science ®Google Scholar
• Abul Hajj Y. J. Relationship between estrogen receptors, 17b˜-hydroxysteroid dehydrogenase and estrogen content in human breast cancer. Steroids 1979; 34: 217–25
   Google Scholar
• Vermeulen A., Deslypere J. P., Paridaens R., Leclercq G., Roy F., Heuson J. C. Aromatase, 17b˜-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer Clin. Oncol. 1986; 22: 515–25
   PubMedGoogle Scholar
• Nguyen B. L., Chetrite G., Pasqualini J. R. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164 384, danazol, and promegestone (R-5020). Breast Cancer Res. Treat. 1995; 34: 139–46
   PubMedGoogle Scholar
• Raju U., Blaustein A., Levitz M. Conjugation of androgens and estrogens by human breast tumors. in vitro. Steroids 1980; 35: 685–95
   Google Scholar
• Pasqualini J. R. Steroid sulphotransferase activity in human hormone-independent MDA-MB-468 mammary cancer cells. Eur. J. Cancer 1992; 28A: 758–62
   PubMedGoogle Scholar
• Lerner L. J., Jordan V. C. Development of antiestrogens and their use in breast cancer: eighth Cain Memorial Award lecture. Cancer Res. 1990; 50: 4177–89
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1–15, and 71-85
   PubMed Web of Science ®Google Scholar
• Brodie A. M. H., Schwarzel W. C., Shaikh A. A., Brodie H. J. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Endocrinology 1977; 100: 1684–95
   PubMed Web of Science ®Google Scholar
• Dowsett M. Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer. J. Steroid Biochem. Molec. Biol. 1990; 37: 1037–41
   Google Scholar
• Brodie A. M. H., Yue W. Basic aspects of aromatase inhibitors and studies of 4-hydroxyandrostenedione in breast cancer patients. Hormone-Dependent Cancer , J. R. Pasqualini, B. S. Katzenellenbogen. Marcel Dekker, Inc., New York BaselHong Kong 1996; 141–54
   Google Scholar
• Bhatnagar A. S., Batzl C., Hausler A., Schieweck J., Lang M., Trunet P. F. Pharmacology of nonsteroidal aromatase inhibitors. Hormone-Dependent Cancer , J. R. Pasqualini, B. S. Katzenellenbogen. Marcel Dekker, Inc., New York BaselHong Kong 1996; 155–68
   Google Scholar
• Pasqualini J. R., Nguyen B. L. Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines. Breast Cancer Res. Treat. 1991; 18: 93–8
   PubMedGoogle Scholar
• Santner S. J., Santen R. J. Inhibition of estrone sulfatase and 17b˜-hydroxysteroid dehydrogenase by antiestrogens. J. Steroid Biochem. Molec. Biol. 1993; 45: 383–90
   PubMedGoogle Scholar
• Prost-Avallet O., Oursin J., Adessi G. L. in vitro effect of synthetic progestogens on estrone sulfatase activity in human breast carcinoma. J. Steroid Biochem. Molec. Biol. 1991; 39: 967–73
   PubMed Web of Science ®Google Scholar
• Pasqualini J. R., Chetrite G., Nguyen B. L., Blacker C., Feinstein M.-C, Maloche C., Talbi M., Delalonde L. Control of estrone sulfatase activity and its expression in human breast cancer. Sex Hormones and Antihormones in Endocrine Dependent Pathology: Basic and Clinical Aspects. Excerpta Medica Intl. Congr. Ser. , M. Motta, M. Serio, 1994; 1064: 257–65
   Google Scholar
• Pasqualini J. R., Chetrite G., Nguyen B. L., Maloche C., Delalonde L., Tali M., Feinstein M. C., Blacker C., Botella J., Paris J. Estrone sulfate-sulfatase and 17b˜-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence. J. Steroid Biochem. Molec. Biol. 1995; 53: 407–12
   PubMed Web of Science ®Google Scholar
• Pasqualini J. R., Chetrite G., Le Nestour E. Control and expression of oestrone sulphatase activities in human breast cancer. J. Endocr. 1996; 150(Suppl.), ), S99-S105
   Google Scholar
• de Aloysio D., Fabiani A. G., Mauloni M., Bottiglioni F. Use of Org OD14 for the treatment of climacteric complaints. Maturitas 1987; 1(Suppl.)49–65, )
   Google Scholar
• Chetrite G., Kloosterboer H. J., Pasqualini J. R. Effect of tibolone (ORG OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res. 1997; 17, in press
   Google Scholar